High Hampton Holdings Corp. (CSE: HC) announced yesterday that the company successfully closed a non-brokered private placement of 31,703,565 units of the Company at a price of $0.60 per unit, to generate $19 million.
Each Unit contains one common share of High Hampton Holdings Corp. and one warrant. Each warrant entitles investors to purchase one additional common share at an exercise price of $0.90 for 24 months following the closing of the offering.
High Hampton Holdings plans to use the proceeds gained in the offering to expand its development in Coachella Valley, to fund company operations, and enter into strategic partnerships.
High Hampton Holding’s wholly owned subsidiary CoachellaGro Corp., is focused on developments in the California cannabis market. Under the company’s umbrella is a 10.8 acre property situated near the proposed cannabis industrial park in Coachella. CoachellaGro has submitted its application for a conditional use permit for development of a full-service production facility in order to serve third party state licensed medical marijuana operators. The facility intended to contain security, infrastructure, equipment, labor, and supplies for growers.
You may be interested
Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio OregonEditor - November 27, 2018
Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…
Wayland Group Enters UK Cannabis Market with Theros Pharma AcquisitionEditor - November 26, 2018
Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…
GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical TrialsEditor - November 26, 2018
GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…